FDA approves Genentech’s treatment for spinal muscular atrophy (SMA) in adults and children 2 months of age and older.
?? of 40 moments published
Tell us what you think about our company, products, or website.
The scientist is not a person who gives the right answers, he’s one who asks the right questions.